title: Injectable contraceptives: how safe are they?
mesh_terms: D000013:Congenital Abnormalities; D009358:Congenital, Hereditary, and Neonatal Diseases and Abnormalities; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003906:Developing Countries; D004194:Disease; D005069:Evaluation Studies as Topic; D005193:Family Planning Services; D006077:Government Agencies; D007267:Injections; D007774:Lactation; D017258:Medroxyprogesterone Acetate; D010679:Philippines; D011640:Public Policy; D012102:Reproductive Control Agents
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D012102:Reproductive Control Agents; D017258:Medroxyprogesterone Acetate
keywords: Congenital Abnormalities; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin--history; Contraceptive Agents, Progestin--religious aspects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--history; Contraceptive Agents--religious aspects; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods; Depo-provera--history; Depo-provera--religious aspects; Depo-provera--side effects; Developing Countries; Diseases; Family Planning; Injectables; Lactation; Medroxyprogesterone Acetate--history; Medroxyprogesterone Acetate--religious aspects; Medroxyprogesterone Acetate--side effects; Neonatal Diseases And Abnormalities; Philippines; Policy; Population Policy; Reproductive Control Agents; Reversibility; Social Policy; Usaid; Use-effectiveness